Skip to main content
. 2014 Nov 13;9(11):e112744. doi: 10.1371/journal.pone.0112744

Figure 4. Osteoclast numbers assayed by tartrate-resistant acid phosphatase staining of femoral sections.

Figure 4

(A)Osteoclast counting results showed that DMOG treatment had no obvious effect on OVX-enhanced osteoclast formation. Original magnification, ×100. Dynamic bone formation illustrated by double tetracycline labeling. (B) DMOG administration promoted bone formation, as evidenced by improved MS/BS, MAR, and BFR/BS. Original magnification, ×200. P<0.05 for comparisons among the groups designated with an asterisk.